INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2023) III. Quarter |
(Jun 30 2023) II. Quarter |
(Mar 31 2023) I. Quarter |
(Dec 31 2022) IV. Quarter |
(Sep 30 2022) III. Quarter |
Total Revenue |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
Cost of Revenue |
- |
- |
- |
- |
- |
Gross
Profit |
0.01 |
0.01 |
0.01 |
0.01 |
0.00 |
Selling, Administration, Marketing |
0.46 |
0.57 |
0.59 |
1.00 |
1.18 |
Depriciation & Amortization |
0.11 |
0.11 |
0.11 |
0.30 |
0.01 |
Research and Development Expense |
0.03 |
0.03 |
0.02 |
0.04 |
0.03 |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
- |
0.00 |
0.00 |
-0.10 |
0.10 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Amortization Of Other Assets |
- |
- |
- |
-0.10 |
- |
Total operating costs including COS |
0.60 |
0.71 |
0.72 |
1.15 |
1.32 |
Operating income/-loss
|
-0.59 |
-0.70 |
-0.71 |
-1.14 |
-1.32 |
Other Deductions / - Income |
Interest expense |
0.06 |
- |
0.06 |
1.64 |
0.06 |
Interest Expense, Borrowings |
- |
0.75 |
- |
- |
- |
Interest Expense, Other |
- |
- |
- |
-1.70 |
- |
Interest income |
- |
- |
- |
0.00 |
- |
Net interest expense/-income |
0.06 |
-0.75 |
0.06 |
0.06 |
0.06 |
Extinguishment of Debt |
0.01 |
- |
-0.17 |
-0.99 |
0.11 |
Loss/ -Gain on Investment |
- |
- |
- |
-0.04 |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.99 |
1.54 |
0.27 |
0.73 |
0.05 |
Change In Fair Value Of Derivative Liability |
- |
- |
- |
- |
0.50 |
Derivative Liability Insufficient Shares |
- |
1.64 |
2.03 |
- |
- |
Derivative Gain Loss On Derivative Net |
- |
0.59 |
-0.10 |
- |
- |
Amortization Of Debt Discount |
- |
- |
-0.04 |
- |
- |
Total costs & expenses |
-0.32 |
3.73 |
2.77 |
0.91 |
2.04 |
Income /-loss before income taxes |
0.33 |
-3.72 |
-2.76 |
-0.90 |
-2.03 |
Income taxes expenses/-benefit |
- |
- |
- |
- |
- |
Income after income taxes |
0.66 |
-3.72 |
-2.76 |
-0.90 |
-2.03 |
Net income/-loss
of other equity |
0.33 |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
0.66 |
-3.72 |
-2.76 |
-0.90 |
-2.03 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
0.66 |
-3.72 |
-2.76 |
-0.90 |
-2.03 |
Noncontrolling interests |
- |
- |
- |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
0.33 |
- |
- |
- |
- |
Income/-loss to shareholder |
0.33 |
-3.72 |
-2.76 |
-0.90 |
-2.03 |
EBIT |
0.39 |
-4.47 |
-2.70 |
-0.84 |
-1.98 |
EBITD |
0.40 |
-4.47 |
-2.70 |
-0.81 |
-1.98 |
EBITDA |
0.40 |
-3.75 |
-2.31 |
-0.42 |
-1.96 |